RadNet (RDNT) Scheduled to Post Quarterly Earnings on Wednesday

RadNet (NASDAQ:RDNT) will release its earnings data after the market closes on Wednesday, May 8th. Analysts expect RadNet to post earnings of ($0.09) per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.

RadNet (NASDAQ:RDNT) last announced its quarterly earnings results on Friday, March 1st. The medical research company reported $0.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.11 by $0.09. RadNet had a return on equity of 4.72% and a net margin of 0.19%. The firm had revenue of $420.38 million for the quarter, compared to the consensus estimate of $410.11 million. During the same period in the prior year, the company posted $0.11 earnings per share. The company’s quarterly revenue was up 9.5% on a year-over-year basis. On average, analysts expect RadNet to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

RadNet Price Performance

Shares of NASDAQ:RDNT opened at $51.20 on Monday. The business has a 50-day simple moving average of $47.00 and a two-hundred day simple moving average of $38.78. RadNet has a fifty-two week low of $25.11 and a fifty-two week high of $52.40. The firm has a market cap of $3.78 billion, a price-to-earnings ratio of -2,558.72 and a beta of 1.69. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.32 and a current ratio of 1.32.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on RDNT shares. Jefferies Financial Group raised their price target on RadNet from $47.00 to $58.00 and gave the stock a “buy” rating in a research note on Friday, March 22nd. Truist Financial reaffirmed a “buy” rating and issued a $55.00 target price (up from $51.00) on shares of RadNet in a report on Thursday, March 28th. StockNews.com downgraded RadNet from a “hold” rating to a “sell” rating in a research report on Thursday, April 11th. Finally, Barclays initiated coverage on RadNet in a research report on Wednesday, March 6th. They issued an “equal weight” rating and a $48.00 price target for the company.

About RadNet

RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.